0
0
38 words
0
Comments
In this exclusive article, Drug Target Review’s Izzy Wood highlights innovative ovarian cancer research from the Institute Krems Bioanalytics.
You are the first to view
https://www.drugtargetreview.com/article/108293/ovarian-cancer-breakthrough-the-potential-of-rhenium-tricarbonyl-trip-as-a-promising-anti-tumour-drug/
Create an account or login to join the discussion